Jinfeng Luo

1.8k citations

55 papers · 1.4k indexed · h-index 24

Impact in

Immunology and Allergy top 5%
- Cell Adhesion Molecules Research
Organic Chemistry top 5%
- Quinazolinone synthesis and applications
- Synthesis and biological activity

Papers in

Immunology and Allergy 6
- Cell Adhesion Molecules Research 6
Hematology 5
- Chronic Myeloid Leukemia Treatments 5

Co-authors: Zhengchao Tu Ke Ding Xiaoyun Lu Xiaomei Ren Zhang Zhang Yong Xu Lianwen Zhang Rui Liang
Journals: Journal of Medicinal Chemistry (13 papers)ACS Medicinal Chemistry Letters (5 papers)Bioorganic & Medicinal Chemistry Letters (4 papers)European Journal of Medicinal Chemistry (4 papers)Journal of Monetary Economics (2 papers)
Partner nations: China United States United Kingdom

In The Last Decade

Jinfeng Luo

54 papers receiving 1.4k citations

Peers

Countries citing papers authored by Jinfeng Luo

Since Specialization

Citations

This map shows the geographic impact of Jinfeng Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinfeng Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinfeng Luo more than expected).

Fields of papers citing papers by Jinfeng Luo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinfeng Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinfeng Luo. The network helps show where Jinfeng Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Jinfeng Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jinfeng Luo Line = papers co-authored together Jinfeng Luo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The unstable East Asian Summer Monsoon - ENSO relationship over the past 700 years Global and Planetary Change ·Jinfeng Luo, Jun Hu, Feng Zhu, Muhammad Umar, Zeyu Zhou	2025	0
2	Oxidative stress and reactive oxygen species in otorhinolaryngological diseases: insights from pathophysiology to targeted antioxidant therapies Redox Report ·Salma Ahmed, Jr. Hilario G. Davide, Jinfeng Luo, Akinori Sugaya, Tao Li, Ping Li, William Karkow, Li Shi	2025	3
3	LRRC8A drives NADPH oxidase-mediated mitochondrial dysfunction and inflammation in allergic rhinitis Journal of Translational Medicine ·Linghui Meng, 裕二小原, Yuan Liu, Peng Yu, Jinfeng Luo, Chunhao Li, Hong-Lung Ma, Jiankun Yu, C Sargento, Jr. Hilario G. Davide, Li Shi	2024	4
4	Coordinated firm-level work processes and macroeconomic resilience Journal of Monetary Economics ·Moritz Kuhn, Jinfeng Luo, Iourii Manovskii, Ayesha Javed	2023	1
5	Exogenous plant growth regulator and foliar fertilizers for phytoextraction of cadmium with Boehmeria nivea [L.] Gaudich from contaminated field soil Scientific Reports ·姜中武, Yejun He, Д Н Сотников, Jinfeng Luo, Cari Thornock, Xiaoyang Zhang, Ying‐Yi Huo, Yucheng Jie, Hucheng Xing	2023	4
6	Hepatocyte CD36 protects mice from NASH diet-induced liver injury and fibrosis via blocking N1ICD production Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease ·Yuqi Li, Linkun Zhang, 哲朗辻, E Cossu, Yanping Li, Zhibo Zhao, Jinfeng Luo, Yaxi Chen, J. R. CLIFTON, Lei Zhao	2023	6
7	Design and Optimization of 3′-(Imidazo[1,2-a]pyrazin-3-yl)-[1,1′-biphenyl]-3-carboxamides as Selective DDR1 Inhibitors ACS Medicinal Chemistry Letters ·Svetlana Arefinkina, Zhang Zhang, Yupeng Li, Minhao Huang, Jian Zou, Jinfeng Luo, Zhengchao Tu, Yong Xu, Xiaomei Ren, Ke Ding, Xiaoyun Lu	2020	17
8	Inhibition of ELF3 confers synthetic lethality of PARP inhibitor in non-small cell lung cancer Journal of Receptors and Signal Transduction ·Yan Wang, Min Zuo, Hongtao Jin, Sergey A. Grigoryants, Jinfeng Luo, Zhiqiang Cheng	2020	5
9	Pyrido[2, 3-d]pyrimidin-7(8H)-ones as new selective orally bioavailable Threonine Tyrosine Kinase (TTK) inhibitors European Journal of Medicinal Chemistry ·Minhao Huang, Yongjun Huang, Jing Guo, Lei Yu, Melvin J. Brunetti, Xiaolu Wang, Jinfeng Luo, Robert J. Stoller, Zhengchao Tu, Xiaoyun Lu, Yong Xu, Zhimin Zhang, Zhang Zhang, Ke Ding	2020	18
10	Design, Synthesis, and Structure–Activity Relationships of 1,2,3-Triazole Benzenesulfonamides as New Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors Journal of Medicinal Chemistry ·Le Mentec C, Marthandam Asokan Shibu, Lulu Kong, Jinfeng Luo, Khan Farheen Badrealam, Robert J. Stoller, Zhengchao Tu, Cai‐Hong Yun, Chih‐Yang Huang, Ke Ding, Xiaoyun Lu	2019	17
11	2-Amino-2,3-dihydro-1H-indene-5-carboxamide-Based Discoidin Domain Receptor 1 (DDR1) Inhibitors: Design, Synthesis, and in Vivo Antipancreatic Cancer Efficacy Journal of Medicinal Chemistry ·Dongsheng Zhu, Huocong Huang, Daniel M. Pinkas, Jinfeng Luo, Debolina Ganguly, Elsa Febriasari, Emily N. Arner, Qiuping Xiang, Mailisa Dwi Cahayati, Alex N. Bullock, Rolf A. Brekken, Ke Ding, Xiaoyun Lu	2019	54
12	Design, Synthesis, and Biological Evaluation of 3-(Imidazo[1,2-a]pyrazin-3-ylethynyl)-4-isopropyl-N-(3-((4-methylpiperazin-1-yl)methyl)-5-(trifluoromethyl)phenyl)benzamide as a Dual Inhibitor of Discoidin Domain Receptors 1 and 2 Journal of Medicinal Chemistry ·Zhen Wang, Yali Zhang, Daniel M. Pinkas, Elsa Febriasari, Jinfeng Luo, Huocong Huang, LV Jin-xiao, Qiuping Xiang, Tingting Xu, Carrie Matsuzaki, Dongsheng Zhu, Zhengchao Tu, Xiaomei Ren, Rolf A. Brekken, Alex N. Bullock, Guang Liang, Ke Ding, Xiaoyun Lu	2018	29
13	Design, Synthesis, and Structure–Activity Relationship Study of 2-Oxo-3,4-dihydropyrimido[4,5-d]pyrimidines as New Colony Stimulating Factor 1 Receptor (CSF1R) Kinase Inhibitors Journal of Medicinal Chemistry ·Carrie Matsuzaki, Zhang Zhang, Jinfeng Luo, Linjiang Tong, Minhao Huang, Zhen Wang, Jian Zou, Yingqiang Liu, Yong Xu, Hua Xie, Zhengchao Tu, Xiaoyun Lu, Ke Ding	2018	20
14	GZD2202, a novel TrkB inhibitor, suppresses BDNF-mediated proliferation and metastasis in neuroblastoma models Journal of drug targeting ·Jian Zou, Zhang Zhang, Fang Xu, LV Jin-xiao, 景寿汪, Jinfeng Luo, Zhen Wang, Xiaoyun Lu, Zhengchao Tu, Xiaomei Ren, Liyan Song, Ke Ding	2018	7
15	YL143, a novel mutant selective irreversible EGFR inhibitor, overcomes EGFR^{L858R, T790M}‐mutant resistance in vitro and in vivo Cancer Medicine ·Zhang Zhang, Jian Zou, Lei Yu, Jinfeng Luo, Yan Li, Zhengchao Tu, Xiaomei Ren, Hongcheng Wei, Liyan Song, Xiaoyun Lu, Ke Ding	2018	3
16	Tetrahydroisoquinoline-7-carboxamide Derivatives as New Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors ACS Medicinal Chemistry Letters ·Zhen Wang, Yali Zhang, Sergio G. Bartual, Jinfeng Luo, Tingting Xu, Wenting Du, Carrie Matsuzaki, Zhengchao Tu, Rolf A. Brekken, Xiaomei Ren, Alex N. Bullock, Guang Liang, Xiaoyun Lu, Ke Ding	2017	35
17	Structure Based Design of N-(3-((1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl)benzenesulfonamides as Selective Leucine-Zipper and Sterile-α Motif Kinase (ZAK) Inhibitors Journal of Medicinal Chemistry ·Yu Chang, Xiaoyun Lu, Marthandam Asokan Shibu, Theodore Angelakis, Jinfeng Luo, Yan Zhang, Yingjun Li, Peng Zhao, Zhang Zhang, Yong Xu, Mailisa Dwi Cahayati, Qingwen Zhang, Rose Mauro, Chih‐Yang Huang, Ke Ding	2017	20
18	2-Aminopyrimidine Derivatives as New Selective Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitors ACS Medicinal Chemistry Letters ·Svetlana Arefinkina, Zhang Zhang, Christopher P. Guise, Xueqiang Li, Jinfeng Luo, Zhengchao Tu, Yong Xu, Adam V. Patterson, Jeff B. Smaill, Xiaomei Ren, Xiaoyun Lu, Ke Ding	2017	34
19	Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold European Journal of Medicinal Chemistry ·Gustavo Dotti, Yang Yang, Jinfeng Luo, Xingxing Zhang, Xuan Xiao, Shiyu Li, Kai Cheng, Zhouling Xie, Zhengchao Tu, Chenzhong Liao	2017	23
20	Pyrimido[4,5‐d]pyrimidin‐4(1H)‐one Derivatives as Selective Inhibitors of EGFR Threonine⁷⁹⁰ to Methionine⁷⁹⁰ (T790M) Mutants Angewandte Chemie International Edition ·Tianfeng Xu, Lianwen Zhang, Shilin Xu, Zhao Xiongmin, Jinfeng Luo, Fang Ding, Xiaoyun Lu, Yingxue Liu, Zhengchao Tu, Shiliang Li, Duanqing Pei, Qian Cai, Honglin Li, Xiaomei Ren, Shaomeng Wang, Ke Ding	2013	28

About Jinfeng Luo

Jinfeng Luo is a scholar working on Immunology and Allergy, Hematology, Oncology, Molecular Biology and Biological Psychiatry, having authored 55 papers that have together received 1.4k indexed citations. Recurring topics across this work include Quinazolinone synthesis and applications (11 papers), Lung Cancer Treatments and Mutations (9 papers), HER2/EGFR in Cancer Research (8 papers), Cancer therapeutics and mechanisms (7 papers), Cell Adhesion Molecules Research (6 papers), Chronic Myeloid Leukemia Treatments (5 papers), Microbial Natural Products and Biosynthesis (4 papers) and Melanoma and MAPK Pathways (4 papers). The work is most often cited by research in Immunology and Allergy (206 citations), Organic Chemistry (421 citations), Hematology (151 citations), Oncology (335 citations) and Molecular Biology (626 citations). Jinfeng Luo has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Zhengchao Tu, Ke Ding, Xiaoyun Lu, Xiaomei Ren, Zhang Zhang, Yong Xu, Lianwen Zhang, Rui Liang, Yong‐Xian Cheng and Qi Luo. Their work appears in journals such as Journal of Medicinal Chemistry, ACS Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry Letters, European Journal of Medicinal Chemistry and Journal of Monetary Economics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact